Drug Safety Business: Start-Up With AERS Filter Eyes Bisphosphonate Events
Executive Summary
A small start-up company has developed a technique to filter the data in FDA’s Adverse Events Reporting System (AERS) database, which it says provides a more accurate analysis of adverse event reports.
You may also be interested in...
FDA Targets Boosting Adverse Event Review ‘Accuracy And Efficiency’
The agency seeks academic institutions and commercial organizations with tools to triage and review post-marketing adverse event drug product case reports submitted to the Adverse Event Reporting System.
FDA Targets Boosting Adverse Event Review ‘Accuracy And Efficiency’
The agency seeks academic institutions and commercial organizations with tools to triage and review post-marketing adverse event drug product case reports submitted to the Adverse Event Reporting System.
Adverse Event Reviews: FDA Needs To Boost ‘Accuracy And Efficiency’
Agency seeks academic institutions and commercial organizations with tools that can conduct automated analysis of case reports from FAERS data.